How Long Does Anxiety Treatment Take? What Affects Recovery Time
Updated: Oct 8
Author: Ukrainian Psychological Hub · Published: October 1, 2026 · Editorial Policy
There is no single evidence-based number of weeks, sessions, or months that answers how long anxiety treatment takes. The timeline changes with the specific anxiety disorder, the treatment being used, symptom severity, avoidance and functional impairment, co-occurring conditions, age, treatment access, and how response is defined. A person can begin improving before an acute treatment course ends, finish a protocol without being in full remission, or reach remission and still need a maintenance phase designed to reduce relapse risk.
That distinction matters because current search results often compress very different questions into one promise such as “8 to 20 sessions” or “3 to 6 months.” Clinical guidance is more disorder-specific. NICE describes high-intensity CBT for generalized anxiety disorder (GAD) as usually 12 to 15 weekly one-hour sessions, while panic-focused CBT is generally 7 to 14 total treatment hours completed within 4 months. NICE guidance for social anxiety disorder describes disorder-specific individual CBT protocols delivered over approximately 4 months. Specific phobia can look very different again: a 2022 meta-analysis found large effects for both single-session and multi-session in-vivo exposure, without a significant pooled difference in effectiveness at post-treatment or follow-up.
This article owns the cross-disorder timeline question: how long treatment can take, what “working” means at different stages, and why recovery time varies. It does not collapse every fear, worry state, panic attack, stress response, or physical symptom into an anxiety disorder. For the diagnostic map, see Anxiety Disorders: Symptoms, Types, Diagnosis, and Treatment.
How Long Does Anxiety Treatment Usually Take?
A practical answer has to separate treatment type from diagnosis. Focused psychotherapy for an anxiety disorder is often designed as a time-limited course measured in weeks or months, but the calendar length differs markedly by protocol. Medication has a different clock: there is an onset and dose-adjustment period, an adequate trial, monitoring over time, and often a continuation phase after improvement. Recovery is broader still because symptom change, functioning, avoidance, confidence, and relapse risk do not necessarily change at the same rate.
For adult GAD, NICE recommends that high-intensity CBT usually consist of 12 to 15 weekly sessions, with fewer if the person recovers sooner and more when clinically required. For panic disorder, the same guideline describes 7 to 14 total hours of CBT, usually in weekly 1- to 2-hour sessions and completed within a maximum of 4 months. For adult social anxiety disorder, NICE describes up to 14 Clark and Wells sessions of 90 minutes or 15 one-hour Heimberg sessions plus a 90-minute exposure session, both delivered over roughly 4 months.
These are treatment-course specifications, not promises that a person will be symptom-free on the final date. A 2026 meta-analysis of 41 randomized studies involving 1,607 adults with GAD found that the number of sessions and overall therapy duration were not simply related to greater treatment effectiveness. That finding is important for expectations: more sessions are not automatically better, and fewer sessions are not automatically sufficient. The treatment has to match the clinical problem and be delivered with adequate content and quality.
Treatment Time Has More Than One Meaning
When people ask how long anxiety treatment takes, they may be asking at least five different questions. Research papers and guidelines do not always use the same outcome definitions, so separating these questions prevents false precision.
First noticeable improvement
This is the point at which something begins to shift: worry occupies less time, panic becomes less frequent or less feared, a person enters situations they previously avoided, sleep or concentration improves, or anxiety interferes less with daily life. Some people notice changes before a protocol ends, while others improve later. There is no defensible cross-disorder rule that everyone should feel substantially better by a particular session.
Completion of the acute treatment course
An acute course is the planned initial block of treatment intended to produce meaningful symptom and functional improvement. For CBT it may be defined by a protocol, such as the GAD, panic, and social-anxiety schedules above. For medication, the acute phase includes enough time for onset, titration when relevant, and assessment of response. Completing an acute course does not itself prove response or remission.
Treatment response
Response generally means a clinically meaningful improvement from baseline. It is not the same as having no anxiety. Bandelow reviewed the problem of defining response and remission across anxiety disorders and noted that research often operationalizes response through change on disorder-specific scales or global improvement ratings. The exact threshold depends on the measure and study.
Remission
Remission means a much lower symptom state, often accompanied by improved functioning, but there is no single universally accepted remission definition across anxiety disorders. A meta-analysis by Springer, Levy, and Tolin showed that reported CBT remission rates varied with the definition used. Older anxiety-treatment literature also frequently grouped OCD and PTSD with anxiety disorders; current DSM-5-TR and ICD-11 classification places those conditions in separate diagnostic families, so historical pooled estimates should not be treated as a current-category recovery rate.
Recovery and maintenance
Recovery usually implies that improvement or remission is sustained over time and daily functioning has stabilized. Maintenance is the phase intended to protect gains, consolidate skills, or reduce relapse risk. These concepts extend beyond the last therapy session or the first month in which a medication appears to help. There is no universal date at which a clinician can declare that every anxiety disorder has permanently ended.
How Long Does CBT Take for Different Anxiety Disorders?
CBT is a family of treatments rather than one identical program. The active ingredients differ by disorder. GAD treatment may target persistent worry, intolerance of uncertainty, cognitive and behavioral patterns, and avoidance. Panic treatment directly addresses catastrophic interpretations of bodily sensations and often includes interoceptive exposure. Social-anxiety CBT targets self-focused attention, safety behaviors, feared social predictions, and behavioral experiments. Specific-phobia treatment centers on exposure to the phobic stimulus or situation. Because the mechanisms and protocols differ, their timelines should not be merged into a single “anxiety CBT” number.
Generalized anxiety disorder
For adult GAD, NICE describes high-intensity CBT as usually 12 to 15 weekly one-hour sessions. The same guideline also recognizes lower-intensity CBT-based self-help formats: non-facilitated self-help should be worked through systematically for at least 6 weeks, while guided self-help uses brief regular support. A 2024 network meta-analysis of 65 randomized trials and 5,048 adults supported CBT as a first-line psychotherapy for GAD. The newer 2026 dose-response meta-analysis cautions against assuming that simply increasing session count or total duration reliably increases effect.
For a fuller disorder-specific treatment discussion, see Generalized Anxiety Disorder Treatment: CBT, Medication, and Self-Help.
Panic disorder
Panic-focused CBT can be relatively compact while still requiring repeated learning. NICE recommends 7 to 14 total hours of CBT, generally delivered weekly in 1- to 2-hour sessions and completed within 4 months. Shorter intensive formats can exist, but the treatment has to retain the active panic-focused components rather than merely shortening supportive contact.
Panic disorder also illustrates why symptom timing can be misleading. A person may still experience bodily arousal during treatment while becoming less frightened of those sensations, reducing anticipatory anxiety and avoidance, and returning to activities. Those changes can represent meaningful progress even before panic attacks have disappeared completely. See Panic Disorder Treatment: CBT, Exposure, Medication, and Self-Help.
Social anxiety disorder
Social-anxiety treatment is often longer than a single focused exposure because therapy targets a network of self-focused attention, feared predictions, safety behaviors, post-event processing, self-imagery, and avoidance. NICE describes Clark and Wells individual CBT as up to 14 sessions of 90 minutes over approximately 4 months. The Heimberg protocol is described as 15 sessions of 60 minutes plus one 90-minute exposure session over approximately 4 months. Supported CBT-based self-help is generally offered over 3 to 4 months.
The disorder-specific page is Social Anxiety Disorder Treatment: CBT, Exposure, Medication, and Self-Help.
Specific phobia
Specific phobia is the clearest reason not to publish a single cross-disorder session count. A 2022 meta-analysis by Odgers and colleagues synthesized clinical studies of in-vivo exposure and found large effects for both single-session and multi-session treatment. There was no significant pooled difference between the formats at post-treatment or follow-up, while single-session exposure was more time-efficient. Phobia subtype moderated outcomes, so even here a one-session model should not be interpreted as a guarantee for every person or every phobia.
See Specific Phobia Treatment: Exposure Therapy and What Evidence Shows for the disorder-specific evidence.
Agoraphobia
Agoraphobia is its own diagnostic territory even though it frequently co-occurs with panic disorder. Treatment often requires repeated in-vivo work across feared situations such as transport, crowds, open spaces, enclosed spaces, or being outside the home alone. The number of visits does not capture the full treatment dose because much of the learning occurs through planned practice between sessions. A panic-disorder schedule should not automatically be copied onto agoraphobia when agoraphobic avoidance is the main clinical problem.
Separation anxiety disorder
Separation anxiety disorder can occur in children, adolescents, and adults. In younger people, treatment often depends on developmental level, parent involvement, school routines, accommodation patterns, and graded return to age-appropriate separation. Those factors make a generic adult CBT session count particularly unhelpful.
For the dedicated clinical treatment page, see Separation Anxiety Disorder Treatment: CBT, Family Support, and Medication.
Selective mutism
Selective mutism is classified among anxiety disorders, but treatment is behaviorally and contextually distinctive. Progress may need to generalize across people, settings, and communication demands rather than appearing as a simple drop in a global anxiety score. School coordination and family involvement can therefore affect calendar time even when treatment is proceeding effectively.
How Long Does Anxiety Medication Take?
Medication has at least three different timeframes: how long it takes before benefit can begin, how long an adequate therapeutic trial should run before judging it, and how long effective treatment is continued after improvement. These are different questions. A fast change in sedation or activation is not the same as the full therapeutic effect, and the absence of immediate benefit does not by itself prove that a medication has failed.
Generalized anxiety disorder medication
For adult GAD, NICE states that the full anxiolytic effect of antidepressant treatment develops gradually, over 1 week or more, and recommends reviewing effectiveness and adverse effects every 2 to 4 weeks during the first 3 months and every 3 months thereafter. If the medication is effective, NICE advises continuing it for at least a year because relapse risk is high. That continuation recommendation is a maintenance decision, not a claim that medication requires a year before it can work.
Panic disorder medication
For panic disorder, NICE uses 12 weeks as an important treatment-review point: if there is no improvement after a 12-week course, another medication class or another form of therapy should be considered as appropriate. When an antidepressant is helping, NICE recommends continuing it for at least 6 months after the optimal dose is reached before tapering is considered. It also recommends follow-up after a new medication is started, including review at 2, 4, 6, and 12 weeks.
Social anxiety disorder medication
For adult social anxiety disorder, NICE describes the full anxiolytic effect of SSRIs or SNRIs as developing gradually over 2 weeks or more. If there is only a partial response to the initial SSRI after 10 to 12 weeks, the guideline recommends adding individual CBT. If symptoms respond well to pharmacological treatment during the first 3 months, NICE recommends continuing medication for at least a further 6 months.
Why medication duration cannot be reduced to an onset number
A statement such as “medication takes four weeks” combines distinct stages into a misleading single number. People differ in tolerability, titration needs, adherence, drug interactions, medical context, and response. Some early adverse effects can appear before therapeutic benefit. A medication may need enough time at a clinically appropriate regimen before its effectiveness can be judged, and effective medication is often continued after response or remission to reduce relapse risk. Medication should be started, monitored, adjusted, and discontinued with a prescriber rather than by a generic online timetable.
Abrupt discontinuation can also create withdrawal symptoms that overlap with anxiety, including dizziness, sleep disturbance, sensory symptoms, gastrointestinal symptoms, sweating, and anxiety itself. NICE explicitly distinguishes this discontinuation problem from the underlying disorder and recommends gradual reduction when antidepressants are stopped.
What Affects Anxiety Recovery Time?
Treatment duration is partly a property of the protocol and partly a property of the clinical situation. Research can identify variables associated with persistence or outcome, but it cannot reliably calculate a personal recovery date from a short list of traits. The most useful factors are those that change assessment, treatment matching, monitoring, or access to active treatment.
The diagnosis and the actual treatment target
Recovery time depends first on what is being treated. Persistent worry, panic attacks, avoidance, social fear, fear of a specific object, separation fear, and selective mutism are not interchangeable phenomena. Panic attacks can occur outside panic disorder; worry can occur in depression, OCD, trauma-related disorders, illness anxiety, substance-related states, or ordinary stress; and medically significant symptoms can resemble anxiety. A poorly matched treatment can look like unusually slow recovery when the deeper problem is that the clinical target has not been identified correctly.
When the diagnosis or medical context is unclear, the relevant next step is reassessment rather than simply extending the same treatment indefinitely. See How Is Anxiety Diagnosed? Assessment, History, and Differential Diagnosis and Anxiety Differential Diagnosis: What Can Look Like an Anxiety Disorder?.
Baseline severity, impairment, and avoidance
Greater clinical burden can be associated with a more persistent course, although it does not determine any individual outcome. A 2021 systematic review of 48 studies involving 29,690 people found that persistence of anxiety disorders was more strongly associated with clinical and psychological characteristics than with sociodemographic characteristics. Higher severity, longer-lasting avoidance, poor post-treatment clinical status, panic attacks, and several other clinical characteristics were associated with persistence.
More recent primary-care evidence also underscores the limits of prediction. In a 2024 secondary analysis of 214 patients with anxiety disorders, baseline anxiety severity was associated with symptom change and remission at 6 months, while machine-learning models did not show useful predictive performance. The practical conclusion is not that severe anxiety has a fixed long recovery time. It is that severity and broader psychopathology should inform monitoring, expectations, and treatment intensity while individual trajectories remain uncertain.
Comorbidity and competing clinical problems
Depression, substance use, sleep disorders, neurodevelopmental conditions, chronic pain, medical illness, and other psychiatric conditions can alter treatment planning and functioning. Comorbidity may require parallel or sequenced care, medication coordination, family or occupational support, or a more complex formulation. It can therefore change calendar time without meaning that an evidence-based anxiety treatment is inherently ineffective.
Whether the treatment matches the disorder
Disorder-specific treatment matters. Panic-focused CBT includes methods that directly test feared bodily sensations. Social-anxiety CBT uses behavioral experiments and work on self-focused attention and safety behaviors. Specific-phobia treatment centers on exposure. A generic package of reassurance, relaxation, or supportive discussion may feel helpful while leaving the central learning process untouched. Treatment mismatch can prolong care because time spent in contact is not the same as exposure to the active therapeutic mechanism.
Treatment quality and between-session learning
For many CBT protocols, learning continues between appointments. In a 2021 study by Conklin and colleagues involving adults treated for GAD, panic disorder, social anxiety disorder, or OCD, higher homework quality was associated with better symptom outcomes and both compliance and quality were associated with treatment completion. Because OCD was included, this study should not be treated as disorder-specific proof for every current anxiety category. It does support the broader point that active treatment engagement is more informative than simply counting therapist visits.
Session frequency and treatment intensity
Calendar duration and total treatment dose are not identical. The same number of treatment hours can be distributed weekly, more intensively, or across a longer period. Intensive exposure formats can compress calendar time for selected problems, while weekly treatment may allow more time for real-world practice between sessions. The 2022 specific-phobia meta-analysis shows that single-session exposure can be highly effective for that disorder, but it would be an error to generalize one-session treatment to GAD, panic disorder, social anxiety disorder, separation anxiety disorder, or selective mutism.
Medication tolerability and monitoring
Medication timelines can lengthen when adverse effects require slower adjustment, when an initial medication is not effective, or when medical conditions and drug interactions constrain options. Conversely, a medication that is tolerated and effective may reach a stable plan without repeated switching. These are prescribing decisions based on clinical response and safety, not a race to meet a generic week number.
Access, continuity, and interruptions
Waiting lists, cost, scheduling, therapist availability, school or work demands, caregiving, transportation, insurance, and treatment interruptions can stretch the calendar even when the amount of actual therapy is modest. Search-intent articles often treat elapsed time as if it were a biological recovery rate; in practice, part of elapsed time can be a health-system and access problem.
Developmental context
Children and adolescents require developmentally appropriate treatment and often more coordination with parents, caregivers, and schools. The AACAP clinical practice guideline supports CBT and SSRIs as evidence-based short-term treatments for pediatric anxiety disorders but does not establish one universal duration for every child or disorder.
The Child/Adolescent Anxiety Multimodal Study (CAMS), a large randomized trial, provides a useful example rather than a universal template. Walkup and colleagues treated 488 young people aged 7 to 17 with separation anxiety disorder, GAD, and/or social phobia using a 12-week acute phase that included 14 CBT sessions in the CBT condition. A subsequent remission analysis showed that response and remission were not equivalent: many young people improved without meeting a stringent remission definition after 12 weeks. This is exactly why “the protocol lasts 12 weeks” should not be rewritten as “recovery takes 12 weeks.”
Does Longer Treatment Work Better?
Not necessarily. The clearest recent evidence comes from adult GAD. In the 2026 preregistered meta-analysis of 41 randomized studies, therapy duration and number of sessions were unrelated to overall treatment effectiveness. Sessions longer than 60 minutes were associated with larger effects in that analysis, while total therapist contact time showed only a trivial relation to effect. The authors emphasized that dose-response research still needs refinement.
This result should not be turned into the opposite slogan that shorter therapy is always just as good. People who need additional treatment should not have care cut off because an average protocol has ended, and a person receiving ineffective or poorly matched treatment should not simply accumulate sessions. Duration is one component of treatment design; diagnosis, active ingredients, fidelity, therapeutic learning, functioning, preference, safety, and response all matter.
How Can You Tell Whether Treatment Is Working Before It Is Finished?
Progress is broader than feeling calm. Anxiety treatment often works by changing behavior and learning before subjective anxiety disappears. Someone with panic disorder may become less afraid of a racing heart. Someone with social anxiety may stop rehearsing every sentence and begin entering social situations. Someone with a specific phobia may approach the feared object while still feeling fear. Someone with GAD may spend less time seeking certainty and more time functioning despite uncertainty.
Useful monitoring therefore looks at symptoms and functioning together: frequency and intensity of worry or panic, avoidance, safety behaviors, ability to complete feared or meaningful activities, sleep, concentration, school or work participation, relationships, and the degree to which anxiety dictates decisions. Disorder-specific scales can help measure change, but a screening score is not a diagnosis and a score reduction is not automatically remission or recovery.
The conceptual distinction is supported by the outcome literature. Bandelow describes response as meaningful improvement and remission as a much lower symptom state with recovery of functioning, while Springer and colleagues showed that remission estimates change when researchers change the remission definition. A useful treatment review therefore asks both “Have symptoms changed?” and “Has life changed?”
When Should Anxiety Treatment Be Reassessed?
A slow week or a difficult exposure is not enough to declare treatment failure. Reassessment becomes more important when there is little or no meaningful improvement after an adequate evidence-based course, symptoms or functioning are worsening, side effects are significant, the treatment does not match the diagnosis, attendance or practice has been disrupted, or another psychiatric, medical, sleep, or substance-related problem may be maintaining the presentation.
Guidelines build reassessment into treatment rather than waiting indefinitely. For panic disorder, NICE calls for a treatment decision at 12 weeks when medication has not produced improvement and recommends specialist referral in many cases after two unsuccessful interventions with continuing significant symptoms. For social anxiety disorder, NICE uses an adequate CBT course and a 10- to 12-week SSRI checkpoint in its next-step recommendations.
Reassessment may confirm that the same treatment should continue, modify how it is delivered, add another evidence-based modality, switch approaches, address comorbidity, or revisit the diagnosis. The phrase “treatment-resistant anxiety” should not be applied simply because a person has had anxiety for a long time or because one treatment did not help. It becomes meaningful only after the adequacy of diagnosis, treatment type, dose or intensity, duration, adherence, tolerability, and competing conditions have been examined.
When medical assessment matters
Anxiety can accompany palpitations, chest discomfort, shortness of breath, dizziness, faint feelings, tremor, tingling, gastrointestinal symptoms, and other physical sensations. New, severe, unexplained, or atypical physical symptoms should not be assigned to anxiety solely because anxiety is present. Severe chest pain, syncope, severe breathing difficulty, a first seizure-like episode, or new focal neurologic symptoms require appropriate medical assessment rather than an online anxiety timeline.
When urgent mental health support matters
If anxiety is accompanied by imminent danger, suicidal intent, inability to maintain basic safety, severe self-neglect, or another acute psychiatric crisis, the immediate question is safety and urgent assessment rather than how many sessions ordinary outpatient treatment usually takes.
What Happens After the Acute Treatment Course?
Finishing the acute phase is a transition point, not proof that treatment has permanently ended. Some people complete therapy and continue practicing skills independently. Others benefit from booster sessions, a longer course, or additional treatment for remaining symptoms. Medication may continue for months after improvement because relapse prevention is part of the treatment plan.
Relapse-prevention evidence supports distinguishing acute response from maintenance. A 2017 systematic review and meta-analysis by Batelaan and colleagues found higher relapse risk after antidepressant discontinuation than continuation among responders in relapse-prevention trials. The historical evidence set included anxiety disorders together with OCD and PTSD, so its pooled result should not be treated as a disorder-specific estimate for the current DSM-5-TR anxiety-disorders category. Its durable lesson is narrower: stopping an effective treatment and maintaining an effective treatment are different clinical phases, and relapse risk is part of duration decisions.
A recurrence of symptoms after improvement also does not mean that earlier treatment was meaningless. Anxiety disorders can have fluctuating or recurrent courses. Skills can be reused, treatment can be resumed or adjusted, and new stressors or clinical changes can require a new assessment. Recovery is better understood as sustained functioning and reduced disorder-related interference than as the permanent elimination of normal fear, worry, arousal, or uncertainty.
How to Think About Your Own Timeline
The most useful personal timeline is built around checkpoints rather than a promised finish date. The first checkpoint is diagnostic: what disorder or symptom pattern is actually being treated, and what competing explanations have been considered? The second is treatment matching: is the intervention evidence-based for that specific problem? The third is implementation: has the treatment been delivered at an adequate intensity and with its active components? The fourth is response: are symptoms, avoidance, and functioning changing? The fifth is maintenance: what protects gains after the acute phase?
This framework also makes room for legitimate individual variation. A person with a circumscribed phobia may complete effective exposure rapidly. Another person with severe GAD, depression, sleep disruption, medical illness, and major functional impairment may need a longer and more layered plan. Neither trajectory establishes a universal rule for everyone else.
Frequently Asked Questions
How many therapy sessions are usually needed for anxiety?
There is no single cross-disorder number. NICE describes adult GAD CBT as usually 12 to 15 weekly sessions, panic-focused CBT as 7 to 14 total treatment hours completed within 4 months, and adult social-anxiety CBT as approximately 14 to 16 meetings over about 4 months depending on the protocol. Specific-phobia exposure can sometimes be delivered effectively in one session.
Can anxiety treatment start working within a few weeks?
Yes, some people notice meaningful changes before an acute treatment course is complete. Early improvement can involve reduced avoidance, better functioning, less fear of symptoms, or lower symptom burden. There is no evidence-based rule that everyone must improve by the same week, and early improvement is not the same as remission.
How long does CBT take to work for anxiety?
CBT timing depends on the disorder and protocol. It is more accurate to use disorder-specific treatment schedules and monitor progress than to quote a universal “CBT works in X weeks” rule. Treatment may be effective even while some anxiety remains because reduced avoidance and better functioning can precede complete symptom remission.
How long does anxiety medication take to work?
Antidepressant effects develop gradually, and an adequate trial is longer than the first days of treatment. NICE notes gradual development of anxiolytic effects and uses disorder-specific review points, including 10 to 12 weeks for partial SSRI response in social anxiety disorder and 12 weeks for major panic-disorder medication decisions. Effective medication is often continued after improvement for relapse prevention.
If I still feel anxious after treatment starts, does that mean it is not working?
No. Normal anxiety remains part of life, and exposure-based treatment deliberately involves contact with feared sensations or situations. Progress can appear first as reduced avoidance, less reliance on safety behaviors, improved functioning, and greater willingness to tolerate anxiety. Persistent severe impairment or no meaningful change after an adequate course should prompt reassessment.
Does having anxiety for years mean treatment will take years?
Not necessarily. Longer symptom duration can be part of a more persistent clinical history, but it does not produce a one-to-one treatment clock. Treatment duration depends on diagnosis, severity, avoidance, comorbidity, treatment match, access, and response. Recent GAD dose-response evidence does not support a simple rule that more therapy time automatically produces better outcomes.
Can a specific phobia improve in one session?
Sometimes. The Odgers et al. meta-analysis found strong outcomes for both single-session and multi-session in-vivo exposure for specific phobia, with no significant pooled difference in effectiveness at post-treatment or follow-up. That evidence is specific to specific phobia and should not be generalized to all anxiety disorders.
Do children and adolescents have the same treatment timeline as adults?
No universal equivalence exists. Pediatric care is developmentally adapted and often involves parents, caregivers, and schools. AACAP supports CBT and SSRIs as short-term evidence-based treatments for youth anxiety, while CAMS shows that a 12-week acute trial can produce response without universal remission. Developmental context and the specific disorder determine the plan.
What if there is no improvement after 12 weeks?
Twelve weeks is a meaningful review point in some medication guidelines, especially panic disorder, but it is not a universal failure threshold for every therapy and every anxiety disorder. A clinician should review diagnosis, treatment adequacy, adherence, side effects, comorbidity, medical and substance-related factors, and whether another evidence-based intervention is indicated.
Does remission mean anxiety will never return?
No. Remission is a low-symptom or near-symptom-free state defined in different ways across studies. It does not mean that normal anxiety has been eliminated or that relapse is impossible. Maintenance, relapse prevention, and the ability to reuse treatment skills remain relevant after remission.
Related Articles
References